Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liming Jiang

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|July 18, 2024
Preoperative short-course radiotherapy followed by chemotherapy and PD-1 inhibitor administration for locally advanced rectal cancer: A study protocol of a randomized phase II/III trial (STELLAR II study)Wenjue Zhang, Yuan Tang, Lichun Wei, et al.
BMC Gastroenterology|July 28, 2022
Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trialJinming Shi, Ning Li, Yuan Tang, et al.
Science (New York, N.Y.)|March 23, 2002
Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infectionsYun Shen, Dejiang Zhou, Liyou Qiu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 29, 2021
Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapyNing Li, Xin Wang, Yuan Tang, et al.
BMC Cancer|February 27, 2022
Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysisNing Li, Xiaoyong Xiang, Dongbin Zhao, et al.
Eclinicalmedicine|October 3, 2022
S-1/temozolomide versus S-1/temozolomide plus thalidomide in advanced pancreatic and non-pancreatic neuroendocrine tumours (STEM): A randomised, open-label, multicentre phase 2 trialYihebali Chi, Lijie Song, Weili Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 7, 2024
Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trialHuiying Ma, Haoyue Li, Tongzhen Xu, et al.
BMC Medicine|February 26, 2026
Minimum 18-week chemotherapy improves survival in locally advanced rectal cancer after neoadjuvant radiotherapy: a post hoc analysis of the STELLAR trialTongzhen Xu, Huiying Ma, Wenjue Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 27, 2023
Pan-Cancer Single-Nucleus Total RNA Sequencing Using snHH-SeqHaide Chen, Xiunan Fang, Jikai Shao, et al.
International Journal of Oncology|December 31, 2016
Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET)Guang Yang, Meng Ji, Jie Chen, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|July 18, 2024
Preoperative short-course radiotherapy followed by chemotherapy and PD-1 inhibitor administration for locally advanced rectal cancer: A study protocol of a randomized phase II/III trial (STELLAR II study)Wenjue Zhang, Yuan Tang, Lichun Wei, et al.
BMC Gastroenterology|July 28, 2022
Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trialJinming Shi, Ning Li, Yuan Tang, et al.
Science (New York, N.Y.)|March 23, 2002
Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infectionsYun Shen, Dejiang Zhou, Liyou Qiu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 29, 2021
Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapyNing Li, Xin Wang, Yuan Tang, et al.
BMC Cancer|February 27, 2022
Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysisNing Li, Xiaoyong Xiang, Dongbin Zhao, et al.
Eclinicalmedicine|October 3, 2022
S-1/temozolomide versus S-1/temozolomide plus thalidomide in advanced pancreatic and non-pancreatic neuroendocrine tumours (STEM): A randomised, open-label, multicentre phase 2 trialYihebali Chi, Lijie Song, Weili Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 7, 2024
Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trialHuiying Ma, Haoyue Li, Tongzhen Xu, et al.
BMC Medicine|February 26, 2026
Minimum 18-week chemotherapy improves survival in locally advanced rectal cancer after neoadjuvant radiotherapy: a post hoc analysis of the STELLAR trialTongzhen Xu, Huiying Ma, Wenjue Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 27, 2023
Pan-Cancer Single-Nucleus Total RNA Sequencing Using snHH-SeqHaide Chen, Xiunan Fang, Jikai Shao, et al.
International Journal of Oncology|December 31, 2016
Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET)Guang Yang, Meng Ji, Jie Chen, et al.
Pageof 15